Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

  1. Home

  • Monday, Oct 27th
    8:00 AM - 9:30 AM Central Time
    27M01: Plenary II (0849–0854)
    Location: W375D-E
    Abstract Moderator: Susan Shenoi, MS, MBBS, RhMSUS – Seattle Children's Hospital and Research Center
    Abstract Moderator: Matlock Jeffries, MD, FACP, FACR – Oklahoma Medical Research Foundation
     CE: 0.00
  • Monday, Oct 27th
    8:00 AM - 8:15 AM Central Time
    0849: Mortality and Major Adverse Cardiac Events (MACE) with GLP-1 Receptor Agonists in Psoriatic Arthritis
    Location: W375D-E
    Presenting Author: Nanuka Tsibadze, MD – Jefferson Health - Einstein
  • Monday, Oct 27th
    8:15 AM - 8:30 AM Central Time
    0850: Single-cell RNA-seq analysis of synovial CD4+ T cells identifies a novel biomarker and therapeutic target in human rheumatoid arthritis
    Location: W375D-E
    Presenting Author: Akinori Murakami, MD – Kyoto University
  • Monday, Oct 27th
    8:30 AM - 8:45 AM Central Time
    0851: Urinary Tenascin C Predicts Kidney Function Loss in Lupus Nephritis
    Location: W375D-E
    Presenting Author: Andrea Fava, MD – Johns Hopkins University
  • Monday, Oct 27th
    8:45 AM - 9:00 AM Central Time
    0852: LEVI-04 Significantly Reduces Bone Marrow Lesions and Symptoms in Knee Osteoarthritis: Results from a Phase II RCT
    Location: W375D-E
    Presenting Author: Simon Westbrook, PhD – Levicept Ltd
  • Monday, Oct 27th
    9:00 AM - 9:15 AM Central Time
    0853: Olink Proteomics Identifies Macrophage Pro-inflammatory Proteins in Maternal Sera Predictive of Fetal Atrioventricular Block Independent of Maternal Health Status
    Location: W375D-E
    Presenting Author: Philip Carlucci, MD – New York University School of Medicine
  • Monday, Oct 27th
    9:15 AM - 9:30 AM Central Time
    0854: The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) Revised Classification Criteria for Axial Spondyloarthritis: Development and Validation in the Classification of Axial SpA Inception Cohort Study
    Location: W375D-E
    Presenting Author: Walter P P. Maksymowych, MD, FRCPC, MRCP, FACP – University of Alberta
  • Monday, Oct 27th
    11:00 AM - 11:30 AM Central Time
    Roundtable/Questions
    Location: W375D-E
    Speaker: C. Thomas Appleton, MD, PhD, FRCPC – The University of Western Ontario
    Speaker: Francis Berenbaum, MD, PhD – Sorbonne University - Saint-Antoine hospital
  • Tuesday, Oct 28th
    8:00 AM - 9:30 AM Central Time
    28T01: Plenary III (1722–1727)
    Location: W375B
    Abstract Moderator: Janet Pope, MD, FRCPC, MPH – University of Western Ontario
    Abstract Moderator: Betsy Barnes, PhD – Northwell Health
     CE: 0.00
  • Tuesday, Oct 28th
    8:00 AM - 8:15 AM Central Time
    1722: Defining Safe Hydroxychloroquine Blood Levels: Time to Switch to Precision Monitoring for Optimized Lupus Care
    Location: W375B
    Presenting Author: Shivani Garg, MD, PhD – University of Madison, School of Medicine and Public Health
  • Tuesday, Oct 28th
    8:15 AM - 8:30 AM Central Time
    1723: Impaired Maintenance of X-Chromosome Inactivation in B Cells, But Not T Cells, Exacerbates Interferon-Driven Systemic Autoimmunity
    Location: W375B
    Presenting Author: Nikhil Jiwrajka, MD, MS – University of Pennsylvania
  • Tuesday, Oct 28th
    8:30 AM - 8:45 AM Central Time
    1724: Pathogenic role of Mucosal-Associated Invariant T cells in Rheumatoid Arthritis.
    Location: W375B
    Presenting Author: Manon Lesturgie-Talarek, MD (she/her/hers) – Paris University
  • Tuesday, Oct 28th
    8:45 AM - 9:00 AM Central Time
    1725: Functional NOTCH4 Variants Drive Vasculopathy and Fibrosis in Systemic Sclerosis.
    Location: W375B
    Presenting Author: Urvashi Kaundal, PhD – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
  • Tuesday, Oct 28th
    9:00 AM - 9:15 AM Central Time
    1726: Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies
    Location: W375B
    Presenting Author: Hu Zeng, PhD – Mayo Clinic
  • Tuesday, Oct 28th
    9:15 AM - 9:30 AM Central Time
    1727: Distribution of Fracture Risk Status and Osteoporosis Treatment Use Among Postmenopausal Women with Osteoporosis in the United States
    Location: W375B
    Presenting Author: Mary Oates, MD – Amgen